Generative AI promises to positively disrupt medical writing in Pharma, across use cases linked to regulatory documentation and safety report summaries.
But as companies have looked to build capabilities in-house, they have found there’s more to leveraging GenAI effectively than simply recruiting the relevant technology skills.
The pharma industry is an ideal candidate for Generative AI (GenAI)-based process transformation, because of its highly regulated and painstakingly templated repeat activities including licence application and maintenance and safety report writing (medical writing).
Check out the rest of the feature here
